Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor PK/PD and Genotype in Healthy Chinese
NCT03092076Phase 1Completed
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- May 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of ticagrelor in acute coronary syndrome (ACS), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Genome-wide genotyping at 10 weeks. Started May 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT03092076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03092076.